The once-daily tablet is the third approved treatment for fibrodysplasia ossificans progressiva (FOP), with CYP3A4 and metformin interaction guidance.
|Videos|March 13, 2017
The Key to Effective Patient Management in Specialty Pharmacy
Author(s)Lauren Santye, Assistant Editor
Mark A. Vineis, vice president of specialty pharmacy at Cardinal Health, discusses the elements of a successful therapy management program in specialty pharmacy.
Advertisement
Mark A. Vineis, vice president of specialty pharmacy at Cardinal Health, discusses the elements of a successful therapy management program in specialty pharmacy.
Advertisement
Related to this article
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Tavapadon, First D1/D5 Agonist for Parkinson Disease
2
Ramantamig's 93.6% ORR and Outpatient CRS Control
3
CagriSema Tops Tirzepatide 5 mg for Weight Loss in REIMAGINE 5
4
Influenza Vaccines Continue to Reduce Severe Disease and Death Across High-Risk Groups, Evidence Review Finds
5